FUND
We fund healthcare industries globally.
Our latest project:
Add impact to your LinkedIn
Keep up with the latest updates, insights, and opportunities driving meaningful change in the healthcare industries
Follow us
Who
We are
ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.
+10,000
people employed
by ARCHIMED companies.
ARCHIMED was founded by healthcare professionals who shared the same passion of making a true impact in the healthcare industries. Watch the video to discover the story of ARCHIMED.
0.00
WHAT
WE DO
We fund, support and scale companies whose activities contribute to improve health outcomes at all levels.
Eurolyser
Instem
CARSO
Clean Biologics (ex Clean Cells)
Fytexia
Micromed
20%
average annual topline growth
of ARCHIMED companies.
HOW
WE DO IT
We join forces with scientists, healthcare professionals, entrepreneurs and investors through our 3 main activities:
SUPPORT
We support healthcare entrepreneurs in their companies’ development.
Our latest project:
DIESSE
RETURN
We deliver superior returns to our investors and to society.
Our latest project:
Clubhouse
SUPPORT
We support healthcare entrepreneurs in their companies’ development.
Our latest project:
DIESSE
RETURN
We deliver superior returns to our investors and to society.
Our latest project:
Clubhouse
LATEST
NEWS
March 11, 2025
ARCHIMED purchases BioVendor Group
BioVendor Group is a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research.
January 27, 2025
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
November 26, 2024
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
As part of the transaction, Nihon Kohden, one of the largest developers and distributors of medical electronic equipment in the world, is entering a joint-venture with ARCHIMED to pursue Ad-Tech’s growth in North America, Europe, and Asia.